Inferring models of multiscale copy number evolution for single-tumor phylogenetics
暂无分享,去创建一个
Russell Schwartz | Alejandro A. Schäffer | E. Michael Gertz | Salim Akhter Chowdhury | Darawalee Wangsa | Kerstin Heselmeyer-Haddad | Thomas Ried | A. Schäffer | E. Gertz | T. Ried | R. Schwartz | K. Heselmeyer-Haddad | S. Chowdhury | Darawalee Wangsa
[1] H. Bandelt,et al. Median-joining networks for inferring intraspecific phylogenies. , 1999, Molecular biology and evolution.
[2] L. Pusztai,et al. Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.
[3] Russell Schwartz,et al. Reconstructing Tumor phylogenies from Heterogeneous Single-Cell Data , 2007, J. Bioinform. Comput. Biol..
[4] H. Lehrach,et al. Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis , 2010, PloS one.
[5] Miklós Csuös,et al. Count: evolutionary analysis of phylogenetic profiles with parsimony and likelihood , 2010, Bioinform..
[6] Henry H. Heng,et al. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution , 2013, Cancer and Metastasis Reviews.
[7] Paul T. Spellman,et al. Methods and challenges in timing chromosomal abnormalities within cancer samples , 2013, Bioinform..
[8] Robert E. Tarjan,et al. Finding optimum branchings , 1977, Networks.
[9] Russell Schwartz,et al. Algorithms to Model Single Gene, Single Chromosome, and Whole Genome Copy Number Changes Jointly in Tumor Phylogenetics , 2014, PLoS Comput. Biol..
[10] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[11] Jörg Rahnenführer,et al. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence. , 2011, International journal of oncology.
[12] C. Maley,et al. Accurate Reconstruction of the Temporal Order of Mutations in Neoplastic Progression , 2011, Cancer Prevention Research.
[13] Sanjay Ranka,et al. Inferring progression models for CGH data , 2009, Bioinform..
[14] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[15] Feng Jiang,et al. Distance-Based Reconstruction of Tree Models for Oncogenesis , 2000, J. Comput. Biol..
[16] Richard M. Karp,et al. A simple derivation of Edmonds' algorithm for optimum branchings , 1971, Networks.
[17] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[18] M. Newton. Discovering Combinations of Genomic Aberrations Associated With Cancer , 2002 .
[19] C. Greenman. Estimation of Rearrangement Phylogeny in Cancer , 2012 .
[20] A. Schäffer,et al. Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression , 2012 .
[21] Russell Schwartz,et al. Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations , 2013, Bioinform..
[22] N. Carter,et al. Estimation of rearrangement phylogeny for cancer genomes. , 2012, Genome research.
[23] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[24] N. Navin,et al. Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.
[25] A. Schäffer,et al. Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. , 2009, The American journal of pathology.
[26] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[27] Feng Jiang,et al. Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..
[28] F. Markowetz,et al. Cancer Evolution: Mathematical Models and Computational Inference , 2014, Systematic biology.
[29] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[30] Jussi Taipale,et al. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. , 2008, Cancer cell.
[31] M. Beaumont. Approximate Bayesian Computation in Evolution and Ecology , 2010 .
[32] Debyani Chakravarty,et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response , 2012, Proceedings of the National Academy of Sciences.
[33] Vasileia Damaskou,et al. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression , 2010, Pathology.
[34] Jens Lagergren,et al. New Probabilistic Network Models and Algorithms for Oncogenesis , 2006, J. Comput. Biol..
[35] Rebecca A Betensky,et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. , 2011, Cancer cell.
[36] M. Gönen,et al. Evolutionary pathways in BRCA1-associated breast tumors. , 2012, Cancer discovery.
[37] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[38] L. Loeb,et al. Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.